Travere Therapeutics (TVTX) Net Income towards Common Stockholders (QoQ) (2012 - 2026)
Travere Therapeutics (TVTX) Net Income towards Common Stockholders (QoQ) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Travere Therapeutics |
5.07 Bn |
4.99 Bn |
102.38 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-102.02% |
| Dec 31, 2024 |
106.78% |
| Sep 30, 2024 |
92.21% |
| Jun 30, 2024 |
-634.95% |
| Mar 31, 2024 |
93.47% |
| Dec 31, 2023 |
-100.66% |
| Sep 30, 2023 |
1,372.06% |
| Jun 30, 2023 |
59.31% |
| Mar 31, 2023 |
-48.35% |
| Dec 31, 2022 |
37.52% |
| Sep 30, 2022 |
10.90% |
| Jun 30, 2022 |
124.95% |
| Mar 31, 2022 |
106.51% |
| Dec 31, 2021 |
-149.09% |
| Sep 30, 2021 |
8.65% |
| Jun 30, 2021 |
27.56% |
| Mar 31, 2021 |
55.72% |
| Dec 31, 2020 |
-439.37% |
| Sep 30, 2020 |
13.50% |
| Jun 30, 2020 |
-3,326.24% |
